Kodiak Sciences (KOD) News Today $36.22 +1.80 (+5.23%) Closing price 04:00 PM EasternExtended Trading$35.81 -0.41 (-1.13%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock KOD Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2026 April 2026 March 2026 February 2026 January 2026 December 2025 November 2025 October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 Time Period Kodiak Sciences Inc. (NASDAQ:KOD) Receives $42.14 Consensus Target Price from BrokeragesMay 19 at 3:27 AM | americanbankingnews.comWhy One Healthcare Fund Increased Its Kodiak Sciences Stake Amid an Eye-Popping RallyMay 17 at 5:28 PM | fool.comWall Street Zen Upgrades Kodiak Sciences (NASDAQ:KOD) to "Hold"May 16, 2026 | americanbankingnews.comKodiak Sciences (KOD) price target increased by 16.91% to 66.30May 14, 2026 | msn.comKodiak Sciences (NASDAQ:KOD) Rating Increased to Buy at Chardan CapitalMay 12, 2026 | americanbankingnews.comChardan Capital upgrades Kodiak Sciences (KOD)May 11, 2026 | msn.comA Look At Kodiak Sciences (KOD) Valuation After Positive Phase 3 GLOW2 Results For ZenkudaMay 11, 2026 | finance.yahoo.comKodiak Sciences (NASDAQ:KOD) Upgraded to Buy at Chardan CapitalMay 11, 2026 | marketbeat.comZenkuda Phase 3 Win and Expanding Pipeline Might Change The Case For Investing In Kodiak Sciences (KOD)May 10, 2026 | finance.yahoo.comKodiak Sciences Inc.: Kodiak Sciences Announces Recent Business Highlights and First Quarter 2026 Financial ResultsMay 8, 2026 | finanznachrichten.deKodiak Sciences Announces Recent Business Highlights and First Quarter 2026 Financial ResultsMay 7, 2026 | prnewswire.comKodiak Sciences (KOD) Expected to Announce Earnings on WednesdayMay 6, 2026 | marketbeat.comKodiak Sciences Inc. $KOD Stock Holdings Decreased by RIA Advisory Group LLCMay 3, 2026 | marketbeat.comKodiak Sciences to Present Pipeline Advances and KSI-101 Clinical Data, Including Results from a MESI Cohort in a Tertiary Care Uveitis Practice, at Upcoming Scientific ConferencesApril 30, 2026 | prnewswire.comKodiak Sciences Inc (KOD): What’s the Chance of Success for Zenkuda?April 24, 2026 | finance.yahoo.comKodiak Sciences Inc. (NASDAQ:KOD) Receives Average Recommendation of "Moderate Buy" from BrokeragesApril 21, 2026 | marketbeat.comKodiak Sciences (NASDAQ:KOD) Hits New 12-Month High - What's Next?April 20, 2026 | marketbeat.comKodiak Sciences (KOD) reports Q4 EPS of ($1.05)April 12, 2026 | msn.comKodiak Sciences (KOD) price target increased by 56.62% to 56.71April 10, 2026 | msn.comJ.P. Morgan Reaffirms Their Buy Rating on Kodiak Sciences (KOD)April 8, 2026 | theglobeandmail.comAnalysts Offer Insights on Healthcare Companies: DBV Technologies SA – American (DBVT) and Kodiak Sciences (KOD)April 8, 2026 | theglobeandmail.comKodiak Sciences GLOW2 Win Puts Zenkuda And Funding Needs In FocusApril 7, 2026 | finance.yahoo.comAssessing Kodiak Sciences (KOD) Valuation After Recent Share Price Momentum And Conflicting SignalsApril 6, 2026 | finance.yahoo.comKodiak Sciences Inc.: Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial ResultsApril 1, 2026 | finanznachrichten.deKodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial ResultsMarch 31, 2026 | prnewswire.comKodiak Sciences: Road To $120March 30, 2026 | forbes.comHow Kodiak Sciences Stock Rises To $120?March 29, 2026 | finance.yahoo.comKodiak Sciences (KOD) Is Up 66.3% After Strong Zenkuda GLOW2 Phase 3 Data - Has The Bull Case Changed?March 28, 2026 | finance.yahoo.comKodiak Sciences stock is surging Friday: What's driving the action?March 27, 2026 | msn.comKodiak Sciences: Shares Up On Positive Eye Disease Data - But I Remain On SidelinesMarch 27, 2026 | seekingalpha.comKodiak climbs on late-stage trial win for diabetic retinopathy therapyMarch 27, 2026 | seekingalpha.comKodiak Sciences shares climb over 71% after strong late-stage trial results for eye drug ZenkudaMarch 27, 2026 | msn.comKodiak Sciences Announces Positive Topline Results in GLOW2, the Second Phase 3 Study in Diabetic Retinopathy, Demonstrating Superiority of Zenkuda(TM) (tarcocimab tedromer ...March 26, 2026 | barrons.comBiggest stock movers Thursday: OLPX, MARA, SMCI, and moreMarch 26, 2026 | seekingalpha.comKodiak Sciences stock surges on positive trial resultsMarch 26, 2026 | za.investing.comKodiak Sciences Shares Climb on Positive Late-Stage Trial ResultsMarch 26, 2026 | marketwatch.comKodiak Sciences' Stock Soars on Results for Diabetic Retionpathy Drug StudyMarch 26, 2026 | marketwatch.comKodiak Sciences stock soars over 60%: what’s behind the sharp rallyMarch 26, 2026 | msn.comKodiak Sciences shares soar after eye drug succeeds in late-stage studyMarch 26, 2026 | msn.comKodiak Sciences shares surge after eye drug succeeds in late-stage studyMarch 26, 2026 | reuters.comKodiak Sciences Announces Positive Topline Results in GLOW2, the Second Phase 3 Study in Diabetic Retinopathy, Demonstrating Superiority of Zenkuda™ (tarcocimab tedromer ...March 26, 2026 | finance.yahoo.comKodiak Sciences Announces Positive Topline Results in GLOW2, the Second Phase 3 Study in Diabetic Retinopathy, Demonstrating Superiority of Zenkuda™ (tarcocimab tedromer) Over ShamMarch 26, 2026 | prnewswire.comKodiak Sciences set to report earnings ahead of key drug trialsMarch 25, 2026 | investing.comAssessing Kodiak Sciences (KOD) Valuation After Recent Share Price Weakness And Strong One Year ReturnMarch 14, 2026 | finance.yahoo.comA Look At Kodiak Sciences (KOD) Valuation After Its Strong One Year Shareholder ReturnFebruary 24, 2026 | finance.yahoo.comKodiak Sciences Stock Up 480% as One Fund Discloses $53 Million BuyFebruary 23, 2026 | fool.comInside a $58 Million Bet on Kodiak Amid $184 Million Offering and Phase 3 Readouts AheadFebruary 19, 2026 | fool.comKodiak Sciences Inc. (KOD) Presents at Angiogenesis, Exudation, and Degeneration 2026 - SlideshowFebruary 9, 2026 | seekingalpha.comKodiak Sciences Inc.: Final APEX Phase 1b Clinical Results for Kodiak's KSI-101 in Macular Edema Secondary to Inflammation to be Presented at Angiogenesis 2026February 4, 2026 | finanznachrichten.deKodiak Sciences (KOD) price target increased by 11.69% to 31.33February 4, 2026 | msn.com Get Kodiak Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for KOD and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. KOD Media Mentions By Week KOD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KOD News Sentiment▼0.760.38▲Average Medical News Sentiment KOD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KOD Articles This Week▼45▲KOD Articles Average Week Get the Latest News and Ratings for KOD and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Kodiak Sciences and its competitors. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies ARWR News Today ABVX News Today CYTK News Today PRAX News Today KRYS News Today IBRX News Today NUVL News Today PCVX News Today KYMR News Today QGEN News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:KOD) was last updated on 5/20/2026 by MarketBeat.com Staff. From Our PartnersTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredAre we ignoring the same signal Wall Street ignored in 1929?In 1929, Irving Weiss spotted a systemic crisis hiding beneath record highs and shorted the market - turning $...Weiss Ratings | SponsoredThe Death of the Nasdaq?The Death of the Nasdaq? Wall Street legend Marc Chaikin's award-winning system turned bearish on software ...Chaikin Analytics | SponsoredWhat Netscape taught us about the next big infrastructure playSpaceX doesn't function without autonomous flight systems, AI navigation, semiconductor chips, and real-time d...True Market Insiders | SponsoredTrump Is Eyeing the Biggest Monetary Shift Since NixonOn August 15, 1971, Nixon ended the Bretton Woods agreement and untethered the dollar from gold. Since that ni...Americas Gold Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kodiak Sciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kodiak Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
